Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

NCT01210443 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class

Stopped Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury.

Conditions

Interventions

Sponsor

Pfizer